Replies to post #94446 on Biotech Values

[genisi]

I don't follow GlobeImmune's vaccine program in particular, but l think that using IL28B genotyping as a mean to personalize treatment in hcv is the right approach. Like you said in #msg-49113863

If it were me or someone in my family, I would want to know the genetic profile to ascertain if an EGFr drug was likely to help. Ditto from the various possible chemo regimens.

Now just replace the indication and therapy.